Immune Pharma (IMNP) Enters $858K Convertible Debentures Purchase Agreement
Tweet Send to a Friend
Immune Pharma (NASDAQ: IMNP) disclosed in an SEC filing:On August 24, 2017, Immune Pharmaceuticals Inc. (the “Company”) entered into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
